Maria J Blanchard
Overview
Explore the profile of Maria J Blanchard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alegre A, Benzo G, Alonso R, Martinez-Lopez J, Jimenez-Ubieto A, Cuellar C, et al.
Oncol Ther
. 2022 Dec;
11(1):83-96.
PMID: 36509945
Introduction: Belantamab mafodotin (BM) is a new anti-BCMA antibody-drug conjugate, recently approved for triple-class relapsed and refractory multiple myeloma (RRMM). We assessed real-world outcomes with BM in patients under the...
2.
Martin-Moro F, Roncancio A, Benito A, Talavera M, Villarrubia J, Blanchard M
Ann Hematol
. 2020 May;
99(11):2705-2706.
PMID: 32458065
No abstract available.
3.
Garcia-Sanz R, Oriol A, Moreno M, Rubia J, Payer A, Hernandez M, et al.
Haematologica
. 2015 Jun;
100(9):1207-13.
PMID: 26069291
This study analyzed the anti-myeloma effect of zoledronic acid monotherapy by investigating patients at the time of asymptomatic biochemical relapse. One hundred patients were randomized to receive either zoledronic acid...
4.
Martinez-Lopez J, Lahuerta J, Pepin F, Gonzalez M, Barrio S, Ayala R, et al.
Blood
. 2014 Mar;
123(20):3073-9.
PMID: 24646471
We assessed the prognostic value of minimal residual disease (MRD) detection in multiple myeloma (MM) patients using a sequencing-based platform in bone marrow samples from 133 MM patients in at...